Diagnosing Inherited Platelet Disorders: Immunofluorescence on the Blood Smear in Comparison With Genetic Testing

On Sunday, July 19, 2021, Carlo Zaninetti of the Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald in Germany, presented results on the comparison between immunofluorescence and genetic testing for diagnosing inherited platelet disorders (IPDs).

Platelet microRNAs Inhibit Primary Tumor Growth via Broad Modulation of Tumor Cell mRNA Expression in Ectopic Pancreatic Cancer in Mice

On Monday, July 19, 2021, Larry Goldfinger of Thomas Jefferson University in Philadelphia presented follow-up research on the inhibitory role for platelets in solid tumor growth mediated by tumor infiltration of platelet microvesicles (microparticles), which are enriched in platelet-derived microRNAs (miRNAs).

Prevention of Arterial and Venous Vascular Events in Symptomatic Peripheral Arterial Disease Patients After Lower Extremity Revascularization in the VOYAGER PAD Trial: Dual Anticoagulant/Antiplatelet

On Monday, July 19, 2021, Scott Darrell Berkowitz, M.D., Clinician/Scientist at CPC Clinical Research and Visiting Research Professor of Medicine at the University of Colorado School of Medicine in Aurora, Colorado, presented findings from late-breaking results of an analysis from the VOYAGER PAD trial.

ISTH Registry on Pregnancy and COVID-19 Associated Coagulopathy (COV-PREG-COAG)- First Report

The ISTH Scientific and Standardization Committee for Women’s Health Issues in Thrombosis and Hemostasis developed the International Registry on Pregnancy and COVID-19 Associated Coagulopathy (COV-PREG-COAG) addressing COVID-19 associated coagulopathy (CAC) in pregnancy.
RSS
12